NORTH CHICAGO, Ill. , Nov. 3, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Jefferies 2017 London Healthcare Conference on Thursday, Nov. 16, 2017 . Bill Chase , executive vice president and chief financial officer, will present at 3:20 a.m. Central time .

- Reports Third-Quarter Diluted EPS of $1.01 on a GAAP Basis; Adjusted Diluted EPS of $1.41, Reflecting Growth of 16.5 Percent - Delivers Third-Quarter Net Revenues of $6.995 Billion; Adjusted Net Revenues Increased 8.8 Percent on an Operational Basis - Third-Quarter Global HUMIRA Sales of $4.701

NORTH CHICAGO, Ill. , Oct. 27, 2017 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) increased the company's quarterly cash dividend by 11 percent from $0.64 per share to $0.71 per share.  The cash dividend is payable February 15, 2018 to shareholders of record at the close of

NORTH CHICAGO, Ill. , Oct. 18, 2017 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the 2017 Credit Suisse Health Care Conference on Wednesday, November 8, 2017 . Bill Chase , executive vice president and chief financial officer, will present at 12 p.m. Central time .

NORTH CHICAGO, Ill. , Oct. 9, 2017 /PRNewswire/ --  AbbVie (NYSE: ABBV) will announce its third-quarter 2017 financial results on Friday, Oct. 27, 2017 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time ( 9 am Eastern).

NORTH CHICAGO, Ill. , Sept. 8, 2017 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $0.64 per share.  The cash dividend is payable Nov. 15, 2017 to stockholders of record at the close of business on Oct. 13, 2017 .

NORTH CHICAGO, Ill. , Sept. 7, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Morgan Stanley 15 th Annual Global Health Care Conference on Tuesday, Sept. 12, 2017 . Richard A. Gonzalez , chairman and chief executive officer, will present at 10:10 a.m. Central time .

- Reports Second-Quarter Diluted EPS of $1.19 on a GAAP Basis; Adjusted Diluted EPS of $1.42, Reflecting Growth of 12.7 Percent - Delivers Second-Quarter Net Revenues of $6.944 Billion; Adjusted Net Revenues Increased 8.9 Percent on an Operational Basis - Second-Quarter Global Humira Sales of

NORTH CHICAGO, Ill. , July 10, 2017 /PRNewswire/ --  AbbVie (NYSE: ABBV) will announce its second-quarter 2017 financial results on Friday, July 28, 2017 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time ( 9 am Eastern).

NORTH CHICAGO , Ill. , June 22, 2017 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $0.64 per share.  The cash dividend is payable Aug. 15, 2017 to stockholders of record at the close of business on July 14, 2017 .